Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01888133 · ClinicalTrials.gov registry record · NA
Adopting a Physically Active Lifestyle Through Organized Walk Events Among Joslin Clinic Patients
A NA study, sponsored by Joslin Diabetes Center.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01888133: Clinical Trial NA study, sponsored by Joslin Diabetes Center.
NCT01888133 is a NA study that was terminated before completion, run by Joslin Diabetes Center. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01888133, a NA study, was terminated before completion, sponsored by Joslin Diabetes Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Can participation in group physical activity, such as a community-based organized group walk, help adult diabetes patients develop a physically active lifestyle? Can such engagement ultimately lead to an improvement in hemoglobin A1c? To address this question, the investigators have designed this pilot study with the aim to investigate the effect of community-based group walks among Joslin adults with diabetes on the development of a physically active lifestyle and glycemic level. The investigators hypothesize that participation in group walking events helps Joslin adults with diabetes engage in physical activity and improves glycemic control.
Interventions
- BEHAVIORAL Group Walk
- BEHAVIORAL Individual Walk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-04 |
| Phase | NA |
Why NCT01888133 stopped before completion
NCT01888133 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Group Walk is the first listed.
NCT01888133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01888133 about?
NCT01888133 is a clinical study titled "Adopting a Physically Active Lifestyle Through Organized Walk Events Among Joslin Clinic Patients". Can participation in group physical activity, such as a community-based organized group walk, help adult diabetes patients develop a physically active lifestyle? Can such engagement ultimately lead to an improvement in hemoglobin A1c? To address this question, the investigators have designed this pi...
What is the current status of trial NCT01888133?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2013-04. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01888133?
The interventions under investigation include: Group Walk (BEHAVIORAL), Individual Walk (BEHAVIORAL).
Who is sponsoring clinical trial NCT01888133?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01888133's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia